Compass Pathways Plc (CMPS)
6.90
+0.18
(+2.68%)
USD |
NASDAQ |
Dec 31, 16:00
6.89
-0.01
(-0.14%)
After-Hours: 20:00
Compass Pathways EPS Diluted (Quarterly): -1.436 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Autolus Therapeutics Plc | -0.2955 |
| Tiziana Life Sciences Ltd. | -- |
| Aptorum Group Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -136.89M |
| Total Expenses (Quarterly) | 136.89M |
| Enterprise Value | 511.39M |
| Earnings Yield | -38.84% |
| Normalized Earnings Yield | -30.07 |